Simbionix USA CorporaTIon, the world's leading provider of medical education and simulation training services, has received a US patent for PROcedure Rehearsal Studio â„¢ (PRS), a patient-specific simulator. Prior to this, the product also received a similar British patent, and the first such US patent among similar products.
As the industry ’s first product, PROcedure Rehearsal Studio uses revolutionary technology developed by Simbionix to support physicians in performing complete intraluminal vascular surgery rehearsals on virtual 3D anatomical models based on patient-specific CT data. The virtual model can then be used to simulate, analyze, and evaluate the surgical treatment plan before the actual operation, which also allows the doctor to be more confident about the upcoming surgery. Once the 3D model is placed in Simbionix's ANGIO Mentor ™ simulation environment, doctors can use realistic tools and intraluminal grafts to perform multiple exercises to evaluate different treatment options.
This patent is based on Simbionix's concept and proprietary core technology. It can simulate image-guided vascular reconstruction surgery according to the patient's 3D medical image input, and conduct actual planning and rehearsal. The unique feature of the Simbionix simulation system is that the 3D segmented model can be placed in the Simbionix ANGIO Mentor practice environment. The practical results can be used as an advanced solution to create an expanding library of unique clinical case studies for training and post-surgical reporting. The patent covers a wide range of applications of this technology, including the use of DICOM (Digital Imaging and Communication in Medicine) mode, the use of 4D data, the study of cases (eg for post-surgery use), and the demonstration of specific procedures to patients.
Mr. Boaz Tal, Chief Financial Officer of Simbionix, also stated: "In obtaining this patent and applications such as the Procedure Rehearsal Studio Carotid Artery (CaroTId), Aortic Endovascular Repair (EVAR) and Thoracic Aortic Endovascular Repair (TEVAR), After three 510 (k) certifications by the Food and Drug Administration (FDA), Simbionix once again demonstrated its important position as a market leader and innovator in the field of medical simulation. Obtaining this patent is a renewal of Simbionix's comprehensive series of products Recognized, and this series of products can provide a variety of innovative solutions to improve clinical standards and optimize surgical results. "
Simbionix USA CorporaTIon is a leading global provider of simulation, training and teaching products for medical professionals and the healthcare industry. The company is committed to providing high-quality products, improving clinical standards and optimizing surgical results.
We are supplier of Disposable Vapes 3000 puffs also distributor a lot of brand. We offer full range of 3000+ Puffs Disposable Vapes, You'll find all Disposable Vape on tsvaping.com.
Disposable Vape 3000 Puffs FOLI BAR Factory Wholesale ;
We offer full range of 3000+ Puffs Disposable Vapes.tsvaping has served thousands of vape wholesalers from worldwide since 2018. Is your e-cigarette wholesale good partner.
The FOLI BAR 3000 Puffs Disposable Vape Wholesale Pen Device is a great way to enjoy your favorite nicotin salt e-liquids.
Wholesale vape 3000 puffs rechargeable disposable Vape Pen . Short Description: Model Number, air glow fun. Brand Name, FOLI. Origin from China.
Vape 3000 Puffs,3000puffs Disposable,E-cigarette 3000,3000 Puffs Vape
TSVAPE Wholesale/OEM/ODM , https://www.tsvaping.com